Global biotech company Incyte (INCY) announced on Friday that it has initiated a Phase 3 clinical trial in collaboration with Novartis (NVS) to test the potential of its Jakavi drug in patients infected with the coronavirus-caused COVID-19. Yahoo
Sunday, April 19, 2020
Incyte, Novartis Initiate Phase 3 Jakavi Drug Study For Coronavirus Treatment
Global biotech company Incyte (INCY) announced on Friday that it has initiated a Phase 3 clinical trial in collaboration with Novartis (NVS) to test the potential of its Jakavi drug in patients infected with the coronavirus-caused COVID-19. Yahoo
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment